HAE
$51.92
Haemonetics
($3.39)
(6.13%)
HAE
Earnings Whisper ®
N/A
3rd Quarter December 2021
Consensus:  $0.75
Revenue:  $268.90 Mil
Tuesday
Feb 8
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HAE reports earnings?
Beat
Meet
Miss

Where is HAE's stock price going from here?
Up
Flat
Down
Stock chart of HAE
Analysts
Summary of analysts' recommendations for HAE
Score
Grade
Pivots
Resistance
$55.91
$55.01
$53.46

$52.56

Support
$51.01
$50.11
$48.56
Tweet
Growth
Description
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Peers
Boston ScientificAbbottStryker3MBecton, DickinsonWatersResMedBaxter InternationalCardiovascular SystemsTeleflex